Directorate Change

GlaxoSmithKline PLC
11 March 2002

Issued - Monday 11 March 2002, London



  SIR RICHARD SYKES TO RETIRE AS CHAIRMAN OF GLAXOSMITHKLINE AT ANNUAL GENERAL
              MEETING; SIR CHRISTOPHER HOGG TO BECOME NEW CHAIRMAN


GlaxoSmithKline plc announces that Sir Richard Sykes, currently the Company's
Chairman, has decided to retire from the Board of Directors with effect from
this year's Annual General Meeting, on May 20th. At that time Sir Christopher
Hogg, currently a Non-executive Director of GlaxoSmithKline, will become
Chairman.


Sir Richard said:- "Having overseen the successful merger of GlaxoSmithKline and
as I approach my 60th birthday in August, I feel now is the right time to
depart. I wish to devote my time and energy to my role as Rector of Imperial
College and leave GlaxoSmithKline in great shape for the future".


Sir Richard was appointed Deputy Chairman and Chief Executive of Glaxo in March
1993. He led Glaxo's acquisition of Wellcome in 1995 and was a principal
architect of Glaxo Wellcome's merger with SmithKline Beecham to form
GlaxoSmithKline at the end of 2000.


In addition to his new role at GlaxoSmithKline, Sir Christopher Hogg is
Non-executive Chairman of Reuters Group plc and Allied Domecq plc (until March
31st 2002), and Non-executive Director of Air Liquide S.A. He joined the Board
of SmithKline Beecham in 1993.


Dr. J.P. Garnier, Chief Executive Officer of GlaxoSmithKline, said: "On behalf
of the Board I would like to pay tribute to Sir Richard, who has made a
tremendous contribution to Glaxo, Glaxo Wellcome and GlaxoSmithKline. He is a
strong and committed ambassador for the pharmaceutical industry, and a great
champion of the UK science base. I wish him well for the future. At the same
time we welcome Sir Christopher as our new Chairman and look forward to
benefiting from his wide-ranging experience and knowledge".


S M Bicknell

Company Secretary


Enquiries:
UK Media enquiries:                                     Martin Sutton            [phone]
                                                        Philip Thomson           [phone]
                                                        Alan Chandler            [phone]

US Media enquiries:                                     Nancy Pekarek            [phone]
                                                        Mary Anne Rhyne          [phone]

European Analyst/Investor enquiries:                    Duncan Learmouth         [phone]
                                                        Anita Kidgell            [phone]

US Analyst/ Investor enquiries:                         Frank Murdolo            [phone]
                                                        Tom Curry                [phone]





                      This information is provided by RNS
            The company news service from the London Stock Exchange